US FDA Raises Concerns at Zydus Lifesciences Gujarat Plant

The US Food and Drug Administration (FDA) has issued a report highlighting five critical issues at a Zydus Lifesciences manufacturing plant located in Gujarat, India. The report, which has not been publicly disclosed, is said to contain observations regarding manufacturing practices and quality control procedures at the facility. This development has placed Zydus Lifesciences under scrutiny, raising concerns about the company's adherence to international regulatory standards. The pharmaceutical company is yet to respond to the FDA's findings.